Literature DB >> 15548525

The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling.

Marcus Buschbeck1, Axel Ullrich.   

Abstract

ERK5 is unique among mitogen-activated protein kinases (MAPKs) in that it contains a large C-terminal tail. We addressed the question of how this tail could affect the signaling capacity of ERK5. Gradual deletion of the C-terminal domains resulted in a drastic increase of ERK5 kinase activity, which was dependent on the up-stream MAPK cascade, thus indicating a possible auto-inhibitory function of the tail. It is interesting that ERK5 was able to autophosphorylate its own tail. Moreover, ERK5, which was found to be expressed in virtually all kinds of cell lines, localized to nuclear as well as cytoplasmic compartments. The localization of ERK5 was determined by its C-terminal domains, which were also required for appropriate nucleocytoplasmic shuttling. Taken together, these results indicate that ERK5 signaling is directed by the presence of its unique C-terminal tail, which might be the key to understanding the key role of ERK5 in MAPK signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548525     DOI: 10.1074/jbc.M412599200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

Review 1.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

Review 2.  Oncogenic signaling of MEK5-ERK5.

Authors:  Van T Hoang; Thomas J Yan; Jane E Cavanaugh; Patrick T Flaherty; Barbara S Beckman; Matthew E Burow
Journal:  Cancer Lett       Date:  2017-01-30       Impact factor: 8.679

3.  Ancestral reconstruction reveals mechanisms of ERK regulatory evolution.

Authors:  Dajun Sang; Sudarshan Pinglay; Rafal P Wiewiora; Myvizhi E Selvan; Hua Jane Lou; John D Chodera; Benjamin E Turk; Zeynep H Gümüş; Liam J Holt
Journal:  Elife       Date:  2019-08-13       Impact factor: 8.140

4.  Nuclear ERK5 inhibits progression of leukemic monocytes to macrophages by regulating the transcription factor PU.1 and heat shock protein HSP70.

Authors:  Ruifang Zheng; George P Studzinski
Journal:  Leuk Lymphoma       Date:  2016-10-17

Review 5.  MAPK signalling: ERK5 versus ERK1/2.

Authors:  Satoko Nishimoto; Eisuke Nishida
Journal:  EMBO Rep       Date:  2006-08       Impact factor: 8.807

Review 6.  Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

Authors:  Evan B Stubbs
Journal:  Exp Neurol       Date:  2020-06-17       Impact factor: 5.330

7.  Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4.

Authors:  Teddy T C Yang; Raymond Y L Yu; Anissa Agadir; Guo-Jian Gao; Roberto Campos-Gonzalez; Cathy Tournier; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

8.  SUMOylation regulates nuclear localization of Krüppel-like factor 5.

Authors:  James X Du; Agnieszka B Bialkowska; Beth B McConnell; Vincent W Yang
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

9.  Laminar flow activation of ERK5 protein in vascular endothelium leads to atheroprotective effect via NF-E2-related factor 2 (Nrf2) activation.

Authors:  Miso Kim; Suji Kim; Jae Hyang Lim; ChuHee Lee; Hyoung Chul Choi; Chang-Hoon Woo
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

10.  A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling.

Authors:  Rajinder S Sawhney; Wensheng Liu; Michael G Brattain
Journal:  J Cell Physiol       Date:  2009-04       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.